Autor: |
Hong, Bong Jin, Swindell, Elden P., MacRenaris, Keith W., Hankins, Patrick L., Chipre, Anthony J., Mastarone, Daniel J., Ahn, Richard W., Meade, Thomas J., O'Halloran, Thomas V., Nguyen, SonBinh T. |
Předmět: |
|
Zdroj: |
Particle & Particle Systems Characterization; Sep2013, Vol. 30 Issue 9, p770-774, 5p |
Abstrakt: |
A polymer‐caged nanobin (PCN) theranostic platform with a doxorubicin (DXR)‐loaded liposomal core and an acid‐sensitive polymer shell that is functionalized with herceptin and GdIII‐based magnetic resonance imaging (MRI) contrast agents is reported. In vitro testing reveals an 120‐fold improvement in cellular GdIII uptake in comparison with clinically approved DOTA‐GdIII, leading to significant T1 MRI contrast enhancement. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|